Document Detail


Buscopan in oesophageal food bolus: is it really effective?
MedLine Citation:
PMID:  15592862     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Food bolus (FB) impaction of the oesophagus is one of the more common emergencies in otolaryngology. These patients are managed either conservatively or surgically. The guideline of the American Society of Gastrointestinal Endoscopy (ASGE) suggests that conservative management either with pharmacological agents or with an effervescent agent should be tried for 24 h usually prior to surgical intervention. Various pharmacological agents have been used to dislodge food bolus with varying success rates. We currently use buscopan as a pharmacological agent to dislodge obstruction. Our objective was to evaluate the efficacy of buscopan in the management of oesophageal food bolus. Dislodgement of food bolus and avoidance of oesophagoscopy were taken as a measure of the effectiveness of buscopan. There is no clear evidence in the literature for the time taken for spontaneous dislodgement or the proportion of cases needing oesophagoscopy. Reviewing the results in the last 5 years in our department, we found that food bolus obstruction was relieved in 68% of the patients who had buscopan and in 63% who did not have buscopan. There was no statistically significant difference in both groups (P = 0.37).
Authors:
S Basavaraj; K R Penumetcha; H R Cable; N Umapathy
Publication Detail:
Type:  Journal Article     Date:  2004-12-09
Journal Detail:
Title:  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery     Volume:  262     ISSN:  0937-4477     ISO Abbreviation:  Eur Arch Otorhinolaryngol     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-08-10     Completed Date:  2006-01-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002937     Medline TA:  Eur Arch Otorhinolaryngol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  524-7     Citation Subset:  IM    
Affiliation:
Sbbki@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Butylscopolammonium Bromide / therapeutic use*
Child
Esophagus*
Female
Food
Foreign Bodies / drug therapy*
Humans
Male
Middle Aged
Parasympatholytics / therapeutic use*
Chemical
Reg. No./Substance:
0/Parasympatholytics; 149-64-4/Butylscopolammonium Bromide
Comments/Corrections
Comment In:
Eur Arch Otorhinolaryngol. 2005 Jul;262(7):523   [PMID:  15592863 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The management of acute oesophageal obstruction from a food bolus. Can we be more conservative?
Next Document:  Mutations in the heterochromatin protein 1 (HP1) hinge domain affect HP1 protein interactions and ch...